procainamide 4-hydroxylamine has been researched along with Lupus Erythematosus, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duncan, SR; Kretz-Rommel, A; Rubin, RL | 1 |
| Adams, LE; Budinsky, RA; Donovan-Brand, R; Hess, EV; Roberts, SM; Sanders, CE | 1 |
2 other study(ies) available for procainamide 4-hydroxylamine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus.
Topics: Adoptive Transfer; Animals; Antibodies, Antinuclear; Autoimmunity; Disease Models, Animal; Female; Humans; Immune Tolerance; Immunity, Cellular; In Vitro Techniques; Lupus Erythematosus, Systemic; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred MRL lpr; Mice, Inbred NZB; Procainamide; T-Lymphocytes; Thymus Gland | 1997 |
Immunomodulatory effects of procainamide metabolites: their implications in drug-related lupus.
Topics: Adult; Female; Hemoglobins; Humans; Immunoglobulins; Interleukin-1; Latex; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Lymphocytes; Macrophages; Male; Microsomes, Liver; Middle Aged; Mitogens; Monocytes; Phagocytosis; Procainamide; Superoxides | 1989 |